M&A

LEO Pharma acquires Bayer’s dermatology unit

https://pharmaphorum.com/news/leo-pharma-acquires-bayers-dermatology-unit/

Pfizer splits into three after failing to sell consumer unit

https://pharmaphorum.com/news/pfizer-splits-into-three-after-failing-to-sell-consumer-unit/

Amazon is absolutely serious about disrupting healthcare

https://pharmaphorum.com/news/amazon-is-serious-about-disrupting-healthcare/

Nektar, BioMarin, and Alnylam top list of biotech M&A targets

https://pharmaphorum.com/news/nektar-biomarin-and-alnylam-top-list-of-biotech-ma-targets/

Lilly buys cancer biotech ARMO for $1.6bn

https://pharmaphorum.com/news/lilly-buys-cancer-biotech-armo-for-1-6bn/

Takeda to cut IT, marketing and sales jobs after Shire merger

https://pharmaphorum.com/news/takeda-to-cut-it-marketing-and-sales-jobs-after-shire-merger/

Takeda takes biggest gamble of 2018 with Shire merger

https://pharmaphorum.com/news/takeda-biggest-gamble-of-2018-with-shire-merger/

Digital health round-up: Nokia sells digital health unit back to Withings co-founder

https://pharmaphorum.com/views-analysis-digital/digital-health-round-up-nokia-sells-digital-health-unit-back-to-withings-co-founder/

J&J could pay $1 billion for oncolytic virus firm BeneVir

https://pharmaphorum.com/news/jj-could-pay-1-billion-for-oncolytic-virus-firm-benevir/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search